Clinical Management of Insomnia Disorders
Summary
Insomnia disorders encompass persistent difficulty initiating or maintaining sleep, early-morning awakening or non-restorative sleep that leads to significant daytime impairment. They may be acute—often linked to life stressors—or chronic, lasting three months or more, and affect an estimated 10–30 per cent of the adult population worldwide. Clinical management begins with a detailed assessment of sleep history, comorbid medical or psychiatric conditions and contributing lifestyle factors. First-line treatment is cognitive behavioural therapy for insomnia (CBT-I), which addresses maladaptive sleep habits and faulty cognitions through structured intervention. When pharmacotherapy is indicated, options include benzodiazepines, non-benzodiazepine receptor agonists (Z-drugs), melatonin receptor agonists and sedating antidepressants, prescribed at the lowest effective dose for the shortest feasible duration to minimise tolerance and adverse effects. Emerging approaches such as non-invasive neuromodulation, digital therapeutics and personalised treatment algorithms are refining clinical pathways. A multidisciplinary framework—integrating primary care, sleep specialists and mental health professionals—supports global efforts to reduce the burden of insomnia and enhance long-term outcomes.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Clinical Management of Insomnia Disorders publication trend
The graph below shows the total number of articles in clinical management of insomnia disorders across all publications each year (not limited to Nature Index journals).
Technical terms
Insomnia disorder: A clinical condition characterised by persistent difficulty with sleep initiation, maintenance or quality, accompanied by daytime dysfunction.
Cognitive behavioural therapy for insomnia (CBT-I): A structured psychological treatment that modifies maladaptive thoughts and behaviours to improve sleep patterns.
Z-drugs: A class of non-benzodiazepine hypnotics (e.g. zolpidem) that act on γ-aminobutyric acid (GABA) receptors to promote sleep with a shorter half-life.
Transcutaneous auricular vagus nerve stimulation (ta-VNS): A non-invasive neuromodulation technique delivering electrical stimulation to the ear’s vagal branches to influence autonomic regulation and sleep.
References
- Distinct Regional Pattern of Sedative Psychotropic Drug Use in South Tyrol: A Comparison with National Trends in Italy. Pharmacy (2025).
- Is transcutaneous auricular vagus nerve stimulation effective and safe for primary insomnia? A PRISMA-compliant protocol for a systematic review and meta-analysis. PLOS ONE (2024).
- Therapeutic efficacy of zolpidem combined with cognitive-behavioral therapy on primary insomnia. Medicine (2019).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.